Some CEOs at pharmaceutical firms likely to be ousted

Rumors have been circulating that some CEOs/presidents will be asked to step down due to poor sales in a tense atmosphere ignited by new drug pricing plan.

Under the owner management, top executives will take responsibility for the poor results so their departure is to be inevitable, a company insider said.

Executive changes at pharmaceutical firms are usually carried out at the beginnin...